Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.

Saved in:
Bibliographic Details
Title: Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Authors: Xiang Y; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Mata-Garrido J; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Fu Y; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Desterke C; Université Paris-Saclay, INSERM, Laboratory of Modèles de cellules souches malignes et thérapeutiques, Villejuif, F-94805, France., Batsché E; Sorbonne Université, Institut de Biologie Paris-Seine, CNRS UMR8256 Biological Adaptation and Aging (IBPS), Laboratory of Epigenetics and RNA Metabolism in Human Diseases, 75005, Paris, France., Hamaï A; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Sedlik C; Institut Curie, PSL University, Department of Translational Research, Inserm U932, Laboratory of Immunity and Cancer, F-75005, Paris, France., Sereme Y; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Skurnik D; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France.; Service de Bactériologie, virologie, parasitologie et hygiène, AP-HP, Hôpital Necker, F-75015, Paris, France., Jalil A; Université Paris Cité, CNRS, SPPIN - Saints-Pères Paris Institute for the Neurosciences, F-75006, Paris, France., Onifarasoaniaina R; Université de Paris Cité, INSERM, CNRS, Institut Cochin, F-75014, Paris, France., Frapy E; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Beche JC; Laboratory of Expérimentation Animale et Transgénèse SFR Necker-Inserm US 24, Paris, France., Alao R; Laboratory of Expérimentation Animale et Transgénèse SFR Necker-Inserm US 24, Paris, France., Piaggio E; Institut Curie, PSL University, Department of Translational Research, Inserm U932, Laboratory of Immunity and Cancer, F-75005, Paris, France., Arbibe L; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France., Chang Y; Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, F-75015, Paris, France. Yunhua.chang-marchand@inserm.fr.
Source: EMBO molecular medicine [EMBO Mol Med] 2024 Oct; Vol. 16 (10), pp. 2652.
Publication Type: Published Erratum
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1757-4684
DOI:10.1038/s44321-024-00141-y